FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) on Thursday reported first-quarter results with profit rising from last year, supported by higher product sales and improved operating income.
Total revenue increased to $6.96 billion in the first quarter of 2026 from $6.67 billion in the same period last year.
Net income climbed to $2.02 billion, or $1.61 per share, compared with $1.32 billion, or $1.04 per share, in the first quarter of 2025.
Gilead also raised its 2026 product sales guidance to a range of $30.0 billion to $30.4 billion, up from its prior outlook of $29.6 billion to $30.0 billion.
GILD is currently trading after hours at $131.79, down $2.27 or 1.69 percent on the Nasdaq.
Copyright(c) 2026 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2026 AFX News
